At the heart of the drug discovery and development process lies an indisputable truth: companies can test for many compounds but, in order to advance to further stages, they need to be able to manufacture it.

Molecule.One is an AI-driven chemist that predicts the best possible synthetic pathways for any desired compound. Their software platform, powered by state-of-the-art machine learning models, discovers the cheapest and easiest way to synthesize any given compound from commercially available molecules. We’re excited to support the team as they build the future of chemistry.